Mankind Pharma Limited (MANKIND)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 1,872.12 2,300.21 2,453.35 2,358.57 2,152.69 2,403.26 2,529.74 2,396.57 2,126.59 2,541.36 2,608.78 2,632.68
YOY Revenue Growth % - - - - 14.99% 4.48% 3.11% 1.61% -1.21% 5.75% 3.12% 9.85%
Other Income 42.46 57.44 58.12 67.23 83.85 94.83 105.76 69.82 219.32 64.22 77.67 56.52
Total Income 1,914.58 2,357.65 2,511.46 2,425.80 2,236.54 2,498.09 2,635.50 2,466.39 2,345.91 2,605.58 2,686.45 2,689.20
Total Expenses + 1,006.34 1,184.86 1,281.77 1,230.96 1,195.56 1,348.81 1,256.46 1,175.96 1,917.16 2,111.92 2,161.82 2,100.49
Cost of Materials Consumed 163.93 213.41 229.96 205.21 213.15 204.24 182.12 179.72 216.76 224.76 230.46 201.14
Employee Benefit Expense 431.07 481.20 500.29 492.68 507.93 522.10 525.86 521.79 536.75 584.87 600.29 617.33
Other Expenses 411.34 490.24 551.52 533.07 474.47 622.47 548.48 474.45 555.44 613.78 604.54 575.16
Operating Profit 865.79 1,115.36 1,171.57 1,127.61 957.13 1,054.45 1,273.28 1,220.61 209.43 429.44 446.96 532.19
OPM % 46.2% 48.5% 47.8% 47.8% 44.5% 43.9% 50.3% 50.9% 9.8% 16.9% 17.1% 20.2%
Profit Before Tax + 355.43 526.39 611.96 576.35 544.86 577.37 770.45 524.25 428.75 493.66 524.63 505.29
Tax Expense 74.45 117.11 139.08 89.28 90.69 63.88 136.02 107.87 46.29 80.90 65.73 55.82
Tax % 20.9% 22.2% 22.7% 15.5% 16.6% 11.1% 17.7% 20.6% 10.8% 16.4% 12.5% 11%
Profit After Tax 280.99 409.28 472.88 487.07 454.17 513.49 634.43 416.38 382.46 412.76 458.90 449.47
EPS (Basic) 7.01 10.22 11.80 12.16 11.34 12.82 15.84 10.35 18.54 10.00 11.12 10.89

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 9,497.80 9,264.81 8,127.15
YOY Revenue Growth % 2.51% 14% -
Other Income 493.21 266.64 162.78
Total Income 9,991.01 9,531.45 8,289.94
Total Expenses + 7,685.02 4,893.15 4,296.06
Cost of Materials Consumed 800.43 861.74 711.05
Employee Benefit Expense 2,131.67 1,982.10 1,701.38
Other Expenses 2,206.69 2,049.30 1,883.64
Operating Profit 1,812.78 4,371.66 3,831.09
OPM % 19.1% 47.2% 47.1%
Profit Before Exceptional 2,305.99 2,259.57 1,562.84
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 2,305.99 2,259.57 1,562.84
Tax Expense 360.51 436.16 314.58
Tax % 15.6% 19.3% 20.1%
Profit After Tax 1,945.48 1,823.41 1,248.26
EPS (Basic) 94.80 45.52 31.16

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 19,031.51 5,858.79 5,758.80
Property, Plant & Equipment 1,941.45 1,811.33 1,435.81
Capital Work in Progress 191.36 112.88 437.83
Non-Current Investments 15,124.52 2,190.62 2,040.76
Goodwill 9.96 6.56 6.56
Other Intangible Assets 1,519.34 1,581.19 1,694.52
Current Assets + 4,794.11 5,556.22 3,609.14
Inventories 1,090.98 1,075.59 1,032.22
Trade Receivables 894.67 749.47 492.64
Cash and Cash Equivalents 200.29 189.20 134.13
Current Investments 1,000.00 1,000.00 1,000.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 41.26 40.06 40.06
Other Equity 14,599.01 9,583.75 7,743.85
Non-Current Liabilities 5,096.53 200.54 168.12
Current Liabilities 4,091.52 1,593.36 1,419.09
Total Liabilities 9,188.05 1,793.90 1,587.21

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 2,322.16 1,982.97 1,798.99
Cash from Investing Activities -12,114.68 -1,919.12 -1,040.61
Cash from Financing Activities 9,783.47 -8.68 -710.41
Net Increase/Decrease in Cash -11.33 55.07 47.96